Long Term 5-Year Survival of Persons with Cryptococcal Meningitis or Asymptomatic Subclinical Antigenemia in Uganda

@inproceedings{Butler2012LongT5,
  title={Long Term 5-Year Survival of Persons with Cryptococcal Meningitis or Asymptomatic Subclinical Antigenemia in Uganda},
  author={Elissa K. Butler and David R Boulware and Paul R Bohjanen and David B Meya},
  booktitle={PloS one},
  year={2012}
}
Data presented previously as an abstract at the 2011 CUGH Global Health Conference in Montreal, Canada on 15 Nov 2011. The long-term survival of HIV-infected persons with symptomatic cryptococcal meningitis and asymptomatic, subclinical cryptococcal antigenemia (CRAG+) is unknown. We prospectively enrolled 25 asymptomatic, antiretroviral therapy (ART)-naïve CRAG+ Ugandans with CD4<100 cells/mcL who received pre-emptive fluconazole treatment (CRAG+ cohort) and 189 ART-naïve Ugandans with… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 33 CITATIONS

A Prospective Evaluation of a Multisite Cryptococcal Screening and Treatment Program in HIV Clinics in Uganda.

  • Journal of acquired immune deficiency syndromes
  • 2018
VIEW 4 EXCERPTS
CITES BACKGROUND & METHODS

Mortality After Cryptococcal Infection in the Modern Antiretroviral Therapy Era.

Matthew A Hevey, Rachel M. Presti, +4 authors Andrej Spec
  • Journal of acquired immune deficiency syndromes
  • 2019

References

Publications referenced by this paper.
SHOWING 1-10 OF 29 REFERENCES

Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS

BJ Park, KA Wannwmuehler, BJ Marston, N Govender, PG Pappas
  • AIDS
  • 2009
VIEW 8 EXCERPTS
HIGHLY INFLUENTIAL

Screening for cryptococcal antigenemia in patients accessing an antiretroviral treatment program in South Africa.

  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2009
VIEW 5 EXCERPTS
HIGHLY INFLUENTIAL